The effect of leucocyte depletion on the quality of fresh-frozen plasma

被引:44
作者
Cardigan, R
Sutherland, J
Garwood, M
Krailadsiri, P
Seghatchian, J
Beard, M
Beckman, N
Williamson, LM
机构
[1] Natl Blood Serv, Birmingham Ctr, Birmingham, W Midlands, England
[2] Natl Blood Serv, E Anglia Ctr, Cambridge, England
[3] Univ Cambridge, Dept Haematol, Cambridge CB2 1TN, England
关键词
leucodepletion; plasma; quality; coagulation; transfusion;
D O I
10.1046/j.1365-2141.2001.02907.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to evaluate the quality of leucodepleted (LD) fresh-frozen plasma (FFP) produced using one of five whole blood filters (Baxter RS2000 & RZ2000, NPBI T2926, Macopharma LST1 and Terumo WBSP) or two plasma filters (Pall LPS1 and Baxter FGR7014). Whole blood or plasma was filtered within 8 h of collection at an ambient temperature. Samples were taken pre- and post filtration for analysis of coagulation factors and complement activation (n = 7-12 for each type of filter). All filtered units (209-286 ml) contained < 5 x 10(6) residual leucocytes and < 30 x 10(9)/l platelets. Statistically significant losses of factors V, VIII, IX, XI and XII and increases in markers of coagulation activation were observed (0-21%), which were dependent on filter type. None of the filters had a significant effect on von Willebrand factor (VWF) multimeric distribution or the activity of VWF and factors II, VII or X. The effect on levels of C3a appeared to be related to the filter surface charge: positively charged filters resulted in C3a generation, whereas negatively charged resulted in C3a removal. None of the observed changes are likely to be clinically significant unless subsequent processing of plasma (such as pathogen inactivation) results in further losses of coagulation factors.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 33 条
[1]   Factor VIII von Willebrand factor complex in methylene blue-treated fresh plasma [J].
Aznar, JA ;
Molina, R ;
Montoro, JM .
TRANSFUSION, 1999, 39 (07) :748-750
[2]   Bradykinin stimulates tissue plasminogen activator release in human vasculature [J].
Brown, NJ ;
Gainer, JV ;
Stein, CM ;
Vaughan, DE .
HYPERTENSION, 1999, 33 (06) :1431-1435
[3]   ACTIVATION OF PLASMINOGEN BY HUMAN PLASMA KALLIKREIN [J].
COLMAN, RW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 35 (02) :273-&
[4]  
Colvin BT, 1997, HAEMOPHILIA, V3, P63, DOI 10.1046/j.1365-2516.1997.00073.x
[5]  
CONTRERAS M, 1992, TRANSFUSION MED, V2, P57
[6]   A monoclonal antibody raised against human β-factor XIIa which also recognizes α-factor XIIa but not factor XII or complexes of factor XIIa with C(1)over-bar esterase inhibitor [J].
Esnouf, MP ;
Burgess, AI ;
Dodds, AW ;
Sarphie, AF ;
Miller, GJ .
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) :874-881
[7]   STABILIZATION OF VONWILLEBRAND-FACTOR IN BANKED BLOOD BY LEUKOCYTE DEPLETION [J].
FARRUGIA, A ;
STREET, A ;
DOUGLAS, S ;
RAINES, G ;
AUMANN, H ;
WHYTE, G ;
SYKES, S ;
OATES, A .
TRANSFUSION MEDICINE, 1993, 3 (01) :51-57
[8]   Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters [J].
Geiger, TL ;
Perrotta, PL ;
Davenport, R ;
Baril, L ;
Snyder, EL .
TRANSFUSION, 1997, 37 (11-12) :1156-1162
[9]   ACTIVATION OF THE CLASSICAL PATHWAY OF COMPLEMENT BY HAGEMAN-FACTOR FRAGMENT [J].
GHEBREHIWET, B ;
SILVERBERG, M ;
KAPLAN, AP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :665-676
[10]   ACTIVATION OF PLASMINOGEN BY HAGEMAN-FACTOR (FACTOR-XII) AND HAGEMAN-FACTOR FRAGMENTS [J].
GOLDSMITH, GH ;
SAITO, H ;
RATNOFF, OD .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01) :54-60